Sanofi Returning Zantac OTC Heartburn Remedy Brand To US Market Formulated With Famotidine

Consumer Health Gets Little Mention In Q1 Results After Sales Dip 7%

Along with its Q1 results including a 7.3% drop in consumer health sales to €1.11bn ($1.35bn), Sanofi announces 10-mg famotidine tablets branded Zantac 360° will be available in the US in June.

Sanofi's consumer health care results factored so little in its latest quarter that it wouldn’t have mentioned a brand in the category if not for its pending relaunch of OTC heartburn remedy Zantac with famotidine as the active ingredient.

More from Ingredients & Safety

More from HBW Insight